EICHOR
● Completed
Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation Toxicity
Condition: Head and Neck Neoplasms · Carcinoma, Squamous Cell · Sponsor: Radboud University Medical Center
About this study
The objective of the UPGRADE-RT trial is to investigate whether de-escalation of elective radiation dose and introduction of an intermediate dose-level in the treatment of head and neck cancer will results in less radiation sequelae and improved quality of life after treatment whilst the recurrence rate in electively irradiated lymph nodes should not be compromised. The full study protocol can be found here: https://doi.org/10.1200/jco-24-02194
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (5)
| VU University Medical Center Amsterdam | Amsterdam, Netherlands | — |
| Radiotherapiegroep, Arnhem | Arnhem, Netherlands | — |
| MAASTRO clinic, Maastricht | Maastricht, Netherlands | — |
| Radboud University Nijmegen Medical Center | Nijmegen, Netherlands | — |
| University Medical Center Utrecht | Utrecht, Netherlands | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02442375